222 related articles for article (PubMed ID: 34228902)
1. Identification of a special cell type as a determinant of the kidney tropism of SARS-CoV-2.
Lin H; Ma X; Xiao F; Su H; Shi Y; Liu Y; Song L; Zhang Z; Zhang C; Peng H
FEBS J; 2021 Sep; 288(17):5163-5178. PubMed ID: 34228902
[TBL] [Abstract][Full Text] [Related]
2. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
Fuentes-Prior P
J Biol Chem; 2021; 296():100135. PubMed ID: 33268377
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease.
Menon R; Otto EA; Sealfon R; Nair V; Wong AK; Theesfeld CL; Chen X; Wang Y; Boppana AS; Luo J; Yang Y; Kasson PM; Schaub JA; Berthier CC; Eddy S; Lienczewski CC; Godfrey B; Dagenais SL; Sohaney R; Hartman J; Fermin D; Subramanian L; Looker HC; Harder JL; Mariani LH; Hodgin JB; Sexton JZ; Wobus CE; Naik AS; Nelson RG; Troyanskaya OG; Kretzler M
Kidney Int; 2020 Dec; 98(6):1502-1518. PubMed ID: 33038424
[TBL] [Abstract][Full Text] [Related]
4. The structural basis of accelerated host cell entry by SARS-CoV-2†.
Seyran M; Takayama K; Uversky VN; Lundstrom K; Palù G; Sherchan SP; Attrish D; Rezaei N; Aljabali AAA; Ghosh S; Pizzol D; Chauhan G; Adadi P; Mohamed Abd El-Aziz T; Soares AG; Kandimalla R; Tambuwala M; Hassan SS; Azad GK; Pal Choudhury P; Baetas-da-Cruz W; Serrano-Aroca Á; Brufsky AM; Uhal BD
FEBS J; 2021 Sep; 288(17):5010-5020. PubMed ID: 33264497
[TBL] [Abstract][Full Text] [Related]
5. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19.
Fu J; Zhou B; Zhang L; Balaji KS; Wei C; Liu X; Chen H; Peng J; Fu J
Mol Biol Rep; 2020 Jun; 47(6):4383-4392. PubMed ID: 32410141
[TBL] [Abstract][Full Text] [Related]
6. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F
Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786
[TBL] [Abstract][Full Text] [Related]
7. Single-cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID-19 infection.
He Q; Mok TN; Yun L; He C; Li J; Pan J
Mol Genet Genomic Med; 2020 Oct; 8(10):e1442. PubMed ID: 32744436
[TBL] [Abstract][Full Text] [Related]
8. Kidney injury molecule-1 is a potential receptor for SARS-CoV-2.
Yang C; Zhang Y; Zeng X; Chen H; Chen Y; Yang D; Shen Z; Wang X; Liu X; Xiong M; Chen H; Huang K
J Mol Cell Biol; 2021 Jul; 13(3):185-196. PubMed ID: 33493263
[TBL] [Abstract][Full Text] [Related]
9. Lung expression of genes putatively involved in SARS-CoV-2 infection is modulated in cis by germline variants.
Cotroneo CE; Mangano N; Dragani TA; Colombo F
Eur J Hum Genet; 2021 Jun; 29(6):1019-1026. PubMed ID: 33649539
[TBL] [Abstract][Full Text] [Related]
10. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
Marchi R; Sugita B; Centa A; Fonseca AS; Bortoletto S; Fiorentin K; Ferreira S; Cavalli LR
Infect Genet Evol; 2021 Jul; 91():104832. PubMed ID: 33812037
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the Severe Acute Respiratory Syndrome Coronavirus-2 Receptor, Angiotensin-Converting Enzyme 2, in Diabetic Kidney Disease: Implications for Kidney Injury in Novel Coronavirus Disease 2019.
Gilbert RE; Caldwell L; Misra PS; Chan K; Burns KD; Wrana JL; Yuen DA
Can J Diabetes; 2021 Mar; 45(2):162-166.e1. PubMed ID: 32917504
[TBL] [Abstract][Full Text] [Related]
12. Can cilia provide an entry gateway for SARS-CoV-2 to human ciliated cells?
Buqaileh R; Saternos H; Ley S; Aranda A; Forero K; AbouAlaiwi WA
Physiol Genomics; 2021 Jun; 53(6):249-258. PubMed ID: 33855870
[TBL] [Abstract][Full Text] [Related]
13. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.
Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M
J Virol; 2021 Jul; 95(15):e0029421. PubMed ID: 33980601
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Cells; 2021 Jun; 10(6):. PubMed ID: 34201214
[TBL] [Abstract][Full Text] [Related]
15. Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19.
Kumar A; Parashar R; Kumar S; Faiq MA; Kumari C; Kulandhasamy M; Narayan RK; Jha RK; Singh HN; Prasoon P; Pandey SN; Kant K
J Med Virol; 2022 Apr; 94(4):1300-1314. PubMed ID: 34811761
[TBL] [Abstract][Full Text] [Related]
16. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.
Puray-Chavez M; LaPak KM; Schrank TP; Elliott JL; Bhatt DP; Agajanian MJ; Jasuja R; Lawson DQ; Davis K; Rothlauf PW; Liu Z; Jo H; Lee N; Tenneti K; Eschbach JE; Shema Mugisha C; Cousins EM; Cloer EW; Vuong HR; VanBlargan LA; Bailey AL; Gilchuk P; Crowe JE; Diamond MS; Hayes DN; Whelan SPJ; Horani A; Brody SL; Goldfarb D; Major MB; Kutluay SB
Cell Rep; 2021 Jul; 36(2):109364. PubMed ID: 34214467
[TBL] [Abstract][Full Text] [Related]
17. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19.
Ahn JH; Kim J; Hong SP; Choi SY; Yang MJ; Ju YS; Kim YT; Kim HM; Rahman MDT; Chung MK; Hong SD; Bae H; Lee CS; Koh GY
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34003804
[TBL] [Abstract][Full Text] [Related]
18. Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review).
Katopodis P; Randeva HS; Spandidos DA; Saravi S; Kyrou I; Karteris E
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34935057
[TBL] [Abstract][Full Text] [Related]
19. Kidney injury molecule-1: a novel entry factor for SARS-CoV-2.
Wan C; Zhang C
J Mol Cell Biol; 2021 Jul; 13(3):159-160. PubMed ID: 33453103
[No Abstract] [Full Text] [Related]
20. A new insight into sex-specific non-coding RNAs and networks in response to SARS-CoV-2.
Askari N; Hadizadeh M; Rashidifar M
Infect Genet Evol; 2022 Jan; 97():105195. PubMed ID: 34954105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
